( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

Should I get breast implants? Should they be saline or silicone? Which style? How much monitoring is needed after surgery?

To help provide relief without the risk of abuse and overdoses, one pharmaceutical company is revealing its new pill designed ...